CUMBERLAND PHARMACEUTICALS INC 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Nov 25, 2013
Insider Transaction Report
Form 4
Lawrence Thomas R
Director
Transactions
- Sale
Common Stock
2013-11-21$4.99/sh−12,000$59,880→ 99,381 total
Footnotes (2)
- [F1]Shares sold to Cumberland Pharmaceuticals Inc.
- [F2]Total now excludes 75,000 shares that had previously been deemed indirectly beneficially owned by Mr. Lawrence. These shares held in a trust were deemed to no longer be indirectly beneficially owned by Mr. Lawrence during 2013.